More articles from Articles
- You have accessRestricted accessAfterwordGraham DutfieldHistory of Pharmacy and Pharmaceuticals, July 2022, 63 (2) 354-362; DOI: https://doi.org/10.3368/hopp.63.2.354Graham DutfieldInternational Governance at the University of Leeds; G.M.Roles: Professor
- You have accessRestricted accessAn Empire of Materia Medica at the Late Medici CourtAshley BuchananHistory of Pharmacy and Pharmaceuticals, July 2022, 63 (2) 149-170; DOI: https://doi.org/10.3368/hopp.63.2.149Ashley BuchananFolger Institute;Roles: Associate Director of Fellowship
- You have accessRestricted access“Own Name,” “No Name,” and “The Plague of Fancy Names”Trademarks in the British Pharmaceutical Market, c. 1875–1920Laura Robson-MainwaringHistory of Pharmacy and Pharmaceuticals, December 2021, 63 (1) 3-39; DOI: https://doi.org/10.3368/hopp.63.1.3Laura Robson-MainwaringCollections Expertise and Engagement Department at The National Archives of the United Kingdom; Laura.Roles: Modern Health Records Specialist
- You have accessRestricted accessMedical Missions, Pharmaceutical Commerce, and Drug ConsumptionThe Introduction of Cocaine to China, 1887–1910Yun HuangHistory of Pharmacy and Pharmaceuticals, December 2021, 63 (1) 61-79; DOI: https://doi.org/10.3368/hopp.63.1.61Yun HuangInternational Center for Drug Policy Studies at Shanghai University;Roles: Postdoctoral researcher
- You have accessRestricted accessThe Battle Between David and GoliathDrug Making and the Dutch Pharmacist versus the International Pharmaceutical Industry, 1865–2020Toine PietersHistory of Pharmacy and Pharmaceuticals, December 2021, 63 (1) 40-60; DOI: https://doi.org/10.3368/hopp.63.1.40Toine PietersFreudenthal Institute and History of Pharmacy and Allied Sciences at the University of Utrecht;Roles: Head and Professor